פורום סרטן ריאות, סרטן ריאה
ויטמין סי וסרטן - מספר מחקרים:

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Intravenous vitamin c dose of more than 100 grams per
day given in slow infusion are not toxic to cancer patients.
Moreover, some cancer patients have had complete
remission of their cancer after a series of high dose
intravenous vitamin C infusions. Also high doses of IV
vitamin C have not interfered with the effect of
conventional therapy and may decrease toxicity of
chemotherapy


The Prospects of Vitamin C in Cancer Therapy

Several lines of evidence support the notion that ascorbate improves the well-being and survival of cancer patients, especially when administered intravenously. The beneficial effects of ascorbate in cancer treatment reflect the ability of ascorbate to inhibit cancer cell proliferation. We also suggest that oral administration of ascorbate can inhibit the immune escape of cancer cells through suppression of IL-18 expression. Importantly, ascorbate is not cytotoxic towards normal cells; thus, ascorbate may be a model antineoplastic agent, prolongling survival and improving the quality of life through selective inhibition of tumor growth.


Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects

In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma.


נראה שיש גם הוכחות קליניות ,בנוסף יש הוכחות רבות של דרכי פעולה במחקרים רבים אחרים.